Skip to main content
TETRATHERIX LIMITED logo

TETRATHERIX LIMITED — Investor Relations & Filings

Ticker · TTX ISIN · AU0000400574 ASX Manufacturing
Open in API
Filings indexed 68 across all filing types
Latest filing 2025-09-07 Regulatory Filings
Country AU Australia
Listing ASX TTX

About TETRATHERIX LIMITED

https://tetratherix.com/

Tetratherix Limited is a regenerative medicine company focused on the development of advanced synthetic scaffolds for bone and tissue repair. The company utilizes proprietary polymer technology to create biocompatible, resorbable materials that mimic the natural extracellular matrix, providing a structural framework for cellular attachment and tissue regeneration. Its primary product line includes synthetic bone graft substitutes designed for use in orthopedic, dental, and maxillofacial surgical procedures. These scaffolds are engineered with high porosity to facilitate vascularization and are gradually replaced by natural bone during the healing process. Tetratherix aims to provide clinical solutions that enhance the body's innate ability to repair complex bone voids and soft tissue defects through innovative material science.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - TTX 5 pages 16.7KB
Regulatory Filings Classification · 95% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) announcement used for the application for quotation of securities. It details the number and type of securities to be quoted, the expiry of escrow periods, and issued capital following quotation. There is no financial performance data, management discussion, or earnings information. The document is a regulatory announcement related to capital markets and securities quotation rather than a financial report or earnings release. This fits the category of a Regulatory Filing (RNS) as it is a formal compliance announcement to the exchange about securities quotation.
2025-09-07 English
Application for quotation of securities - TTX 5 pages 16.7KB
Share Issue/Capital Change Classification · 95% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) announcement used for the application for quotation of securities. It details the number and type of securities to be quoted, specifically restricted securities where the escrow period has expired or is about to expire. The document includes information about the entity, the securities, and issued capital following quotation. There is no financial report, earnings data, or management discussion. This type of document is a regulatory announcement related to capital markets and securities quotation, fitting the category of Share Issue/Capital Change announcements rather than a full financial report or other categories.
2025-09-04 English
Notice of Escrow Release 1 page 117.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 29th August 2025. It discusses the release of restricted securities from escrow, specifying quantities and release dates. It references the upcoming release of the FY25 Results and Annual Report but does not contain any financial data or the report itself. The document is short (1702 characters) and serves as a notification about securities escrow release, not a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2025-08-28 English
Appendix 4E and 2025 Annual Report 108 pages 11.4MB
Regulatory Filings
2025-08-27 English
2025 Financial Results Announcement 10 pages 1.3MB
Annual Report Classification · 95% confidence The document is an ASX announcement dated 28 August 2025 presenting the financial results for the year ended 30 June 2025. It includes detailed financial data such as revenue, losses, cash flow, R&D expenditure, and net asset position. The text references the company's IPO, capital structure, and strategic priorities. It contains comprehensive financial statements and analysis for the full fiscal year, including profit and loss, cash flow, and statement of financial position. The document is not merely an announcement of a report but contains substantive financial data and detailed management commentary on the financial results and outlook. Therefore, it fits the definition of an Annual Report (10-K) type document, as it covers the full fiscal year financial performance and company activity in detail.
2025-08-27 English
Appendix 4G and Corporate Governance Statement 31 pages 1.7MB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a form used by ASX-listed entities to confirm compliance with corporate governance disclosure requirements. The document includes a key to where governance disclosures can be found, and it explicitly states it is not a substitute for the corporate governance statement itself. The document is a regulatory filing required to be lodged with ASX alongside the annual report but is not the annual report or the governance statement itself. It is a compliance and disclosure verification form related to governance practices, fitting the category of Regulatory Filings (RNS) as it does not contain financial statements or detailed governance reports but serves as a regulatory compliance document.
2025-08-27 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.